Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) — Net Asset Momentum
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) recorded a net asset momentum of 3.2% as of December 2025, with net assets of CN¥1.69 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 002864 book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Net Asset Momentum (2013–2025)
This chart tracks Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's year-over-year net asset growth across 13 annual reporting periods from 2013 to 2025. The most recent momentum reading is +3.2%, with net assets of CN¥1.69 Billion CNY as of December 2025. For live market cap and overall valuation, see market cap of Shaanxi Panlong Pharmaceutical Group Lim.
Annual Net Asset History for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)
The table below shows the complete annual net asset history for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of Shaanxi Panlong Pharmaceutical Group Lim to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.69 Billion | CN¥2.32 Billion | CN¥633.75 Million | ▲ +3.2% |
| 2024 | CN¥1.64 Billion | CN¥2.28 Billion | CN¥642.84 Million | ▲ +5.5% |
| 2023 | CN¥1.55 Billion | CN¥2.13 Billion | CN¥573.76 Million | ▲ +63.7% |
| 2022 | CN¥947.60 Million | CN¥1.93 Billion | CN¥983.18 Million | ▲ +17.4% |
| 2021 | CN¥807.21 Million | CN¥1.33 Billion | CN¥522.97 Million | ▲ +9.7% |
| 2020 | CN¥735.66 Million | CN¥1.16 Billion | CN¥426.89 Million | ▲ +9.0% |
| 2019 | CN¥674.71 Million | CN¥928.88 Million | CN¥254.17 Million | ▲ +10.3% |
| 2018 | CN¥611.60 Million | CN¥817.84 Million | CN¥206.24 Million | ▲ +10.1% |
| 2017 | CN¥555.58 Million | CN¥752.93 Million | CN¥197.34 Million | ▲ +69.5% |
| 2016 | CN¥327.82 Million | CN¥504.50 Million | CN¥176.68 Million | ▲ +13.5% |
| 2015 | CN¥288.89 Million | CN¥433.33 Million | CN¥144.44 Million | ▲ +17.3% |
| 2014 | CN¥246.19 Million | CN¥401.26 Million | CN¥155.06 Million | ▲ +16.8% |
| 2013 | CN¥210.84 Million | CN¥342.39 Million | CN¥131.55 Million | — |